Creating synthetic versions of cell communication vehicles for better drug delivery
Bottom-up, high-throughput prototyping of extracellular vesicle mimetics using cell-free synthetic biology
This study is working on creating new, lab-made versions of tiny structures that help cells talk to each other, which could be used to deliver medicine more effectively, making it easier for patients to get the treatments they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11045722 on NIH RePORTER |
What this research studies
This research focuses on developing synthetic mimetics of extracellular vesicles (EVs), which are natural cell-derived structures that facilitate communication between cells and have potential as drug delivery systems. The project aims to overcome challenges associated with native EVs, such as low production yield and variability, by using a cell-free synthetic biology approach to create these mimetics in a high-throughput manner. By identifying and isolating the critical components of EVs, the research seeks to standardize and improve the production of these therapeutic vehicles, making them more effective for clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that could benefit from advanced drug delivery methods, such as cancer or autoimmune diseases.
Not a fit: Patients who do not have conditions requiring innovative drug delivery systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more reliable and effective drug delivery systems that enhance treatment outcomes for various diseases.
How similar studies have performed: Other research has shown promise in using synthetic biology approaches to create therapeutic vehicles, indicating potential success for this novel method.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Tan, Cheemeng — University of California at Davis
- Study coordinator: Tan, Cheemeng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.